AMEX · ITDF
iShares LifePath Target Date 2050 ETF
$41.10-$0.60 (-1.44%)
iShares LifePath Target Date 2050 ETF’s quoted price sits in the upper half of its reported 52-week range, 4.31% below the high.
Loading market information…
NASDAQ · HEJD · USD
Stock price, dividends
Quote as of Sep 4, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
VictoryShares Hedged Equity Income ETF’s quoted price sits in the upper half of its reported 52-week range, 0.47% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
VictoryShares Hedged Equity Income ETF’s forward annual dividend is $4.14 per share, paid monthly. The forward yield is 15.08% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The VictoryShares Hedged Equity Income ETF (HEJD) focuses its investments on U.S. companies that pay dividends. It concurrently utilizes a hedging strategy by shorting equity index futures that are highly correlated with the market. This dual approach aims to diminish overall market risk, delivering a dynamic and consistent hedge that adapts to market shifts. The fund's objective is to capture growth from the equity market while actively managing risk. This design strives to reduce portfolio volatility and limit potential downside exposure compared to conventional long-only investment strategies. HEJD contributes to portfolio diversification, showing a moderate correlation to the wider U.S. equity market and a minimal correlation to fixed income assets. In addition to its main goal of achieving capital appreciation, the ETF also endeavors to provide investment income. This fund stands as a highly systematic, transparent, and easily tradable alternative investment, benefiting from continuous professional oversight.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 04:42 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$41.10-$0.60 (-1.44%)
iShares LifePath Target Date 2050 ETF’s quoted price sits in the upper half of its reported 52-week range, 4.31% below the high.
$39.70-$0.49 (-1.23%)
iShares LifePath Target Date 2045 ETF’s quoted price sits in the upper half of its reported 52-week range, 3.71% below the high.
$36.17$0.00 (0.0%)
Invesco Nasdaq Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$34.83-$0.22 (-0.62%)
iShares LifePath Target Date 2030 ETF’s quoted price sits in the upper half of its reported 52-week range, 2.3% below the high.
$69.60-$2.81 (-3.88%)
Pacer US Export Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 8.23% below the high.
$39.41-$0.23 (-0.58%)
Touchstone Dividend Select ETF’s quoted price sits in the upper half of its reported 52-week range, 1.77% below the high.
$37.86-$0.15 (-0.41%)
Federated Hermes MDT Large Cap Value ETF’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
$63.71-$0.28 (-0.44%)
AXS Knowledge Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 2.35% below the high.
